Published in Clin Pharmacol Ther on November 24, 2010
Tissue factor, blood coagulation, and beyond: an overview. Int J Inflam (2011) 1.05
Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels. Mol Cell Biol (2013) 1.00
Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans. Pharmacogenet Genomics (2012) 0.94
Genomic structure and variation of nuclear factor (erythroid-derived 2)-like 2. Oxid Med Cell Longev (2013) 0.93
Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy. J Thromb Haemost (2013) 0.75
Genetic Polymorphisms of Transcription Factor NRF2 and of its Host Gene Sulfiredoxin (SRXN1) are Associated with Cerebrovascular Disease in a Finnish Cohort, the TAMRISK Study. Int J Med Sci (2016) 0.75
Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation (2007) 3.17
Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem Biophys Res Commun (1987) 2.01
Effect of paraoxonase-1 polymorphism on clinical outcomes in patients treated with clopidogrel after an acute myocardial infarction. Clin Pharmacol Ther (2011) 1.67
Cloning and sequencing of porcine LH-hCG receptor cDNA: variants lacking transmembrane domain. Science (1989) 1.54
Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost (2012) 1.52
Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D). J Med Genet (2014) 1.36
In vivo functional protein-protein interaction: nuclear targeted hsp90 shifts cytoplasmic steroid receptor mutants into the nucleus. Proc Natl Acad Sci U S A (1994) 1.34
Cloning, sequencing and expression of human TSH receptor. Biochem Biophys Res Commun (1990) 1.23
Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging. J Hypertens Suppl (1992) 1.22
Cloning and sequence analysis of rabbit progesterone-receptor complementary DNA. Proc Natl Acad Sci U S A (1986) 1.17
Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism: results from the EDITH Study. J Thromb Haemost (2007) 1.16
Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation (1996) 1.16
Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments. J Pharmacol Exp Ther (1997) 1.15
Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients. Clin Pharmacol Ther (2012) 1.08
Effect of grapefruit juice on digoxin pharmacokinetics in humans. Clin Pharmacol Ther (2001) 1.05
Peripheral neuropathy with hypomyelination, chronic intestinal pseudo-obstruction and deafness: a developmental "neural crest syndrome" related to a SOX10 mutation. Ann Neurol (2000) 1.05
Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Int J Epidemiol (1990) 1.03
Recessive inheritance of a new point mutation of the PMP22 gene in Dejerine-Sottas disease. Ann Neurol (1999) 1.03
Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture. Cancer Res (1995) 1.02
Risk factors for early carotid atherosclerosis in middle-aged French women. Arterioscler Thromb (1991) 1.02
The Roussy-Lévy family: from the original description to the gene. Ann Neurol (1999) 0.99
Soluble thrombomodulin as predictor of incident coronary heart disease. Lancet (1999) 0.96
Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity. Clin Pharmacol Ther (2000) 0.96
Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome. J Pediatr (1987) 0.95
Mechanisms of progesterone receptor export from nuclei: role of nuclear localization signal, nuclear export signal, and ran guanosine triphosphate. Mol Endocrinol (1998) 0.95
Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes. Chem Res Toxicol (2001) 0.95
Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study. J Thromb Haemost (2009) 0.93
A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis. Ann Rheum Dis (2007) 0.91
Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: contribution of genetic factors, dose-dependent clearance, and interaction with amiodarone. Clin Pharmacol Ther (1994) 0.91
Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population. Arterioscler Thromb Vasc Biol (1997) 0.91
Diagnostic accuracy of compression ultrasonography for the detection of asymptomatic deep venous thrombosis in medical patients--the TADEUS project. Thromb Haemost (2001) 0.90
Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics. Ann Endocrinol (Paris) (2010) 0.90
Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assay. Thromb Haemost (1989) 0.89
Early acenocoumarol overanticoagulation among cytochrome P450 2C9 poor metabolizers. Pharmacogenetics (2001) 0.89
The therapeutic management of chronic pain in ambulatory care patients aged 65 and over in France: the S.AGES Cohort. Baseline data. J Nutr Health Aging (2013) 0.88
Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women. J Clin Endocrinol Metab (2008) 0.87
Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics. Clin Pharmacol Ther (2007) 0.86
Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study. J Thromb Haemost (2006) 0.86
Assessment of the risk for venous thromboembolism among users of hormone replacement therapy. Drugs Aging (1999) 0.85
Identifying and preventing adverse drug events in elderly hospitalised patients: a randomised trial of a program to reduce adverse drug effects. J Nutr Health Aging (2010) 0.85
Effects of long term administration of ticlopidine on platelet function and hemostatic variables. Thromb Res (1980) 0.84
Further evidence that activated factor VII is related to plasma lipids. Br J Haematol (1985) 0.84
Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration. Circulation (2005) 0.83
Genetic and environmental risk factors for oral anticoagulant overdose. Eur J Clin Pharmacol (2003) 0.83
Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome. Mol Genet Metab (2005) 0.83
Two unusual occurrences of trichomoniasis: rapid species identification by PCR. J Clin Microbiol (2008) 0.83
Early carotid atherosclerosis in healthy middle-aged women. A follow-up study. Stroke (1993) 0.83
Is diclofenac a valuable CYP2C9 probe in humans? Eur J Clin Pharmacol (2001) 0.83
In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA. Proc Natl Acad Sci U S A (1993) 0.83
Monoclonal antibodies against luteinizing hormone receptor. Immunochemical characterization of the receptor. Endocrinology (1990) 0.83
Longitudinal associations between plasma viscosity and cardiovascular risk factors in a middle-aged French population. Atherosclerosis (1993) 0.82
Is low endogenous cortisol a risk factor for asthma? Am J Respir Crit Care Med (1999) 0.82
Thrombomodulin promoter mutations, venous thrombosis, and varicose veins. Arterioscler Thromb Vasc Biol (2001) 0.82
Survival and functions of encapsulated porcine hepatocytes after allotransplantation or xenotransplantation without immunosuppression. Surgery (2001) 0.81
Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis (1996) 0.81
Relationship between sex hormones and haemostatic factors in healthy middle-aged men. Atherosclerosis (1988) 0.81
CYP2C9*3 Loss-of-Function Allele Is Associated With Acute Upper Gastrointestinal Bleeding Related to the Use of NSAIDs Other Than Aspirin. Clin Pharmacol Ther (2010) 0.81
Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors. J Neural Transm (Vienna) (2014) 0.80
[A new, rapid and robust genotyping method for CYP2C9 and MDR1]. Ann Biol Clin (Paris) (2003) 0.80
Assessment of CYP2D6 and CYP2C19 activity in vivo in humans: a cocktail study with dextromethorphan and chloroguanide alone and in combination. Clin Pharmacol Ther (1999) 0.80
Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium. Hepatology (1999) 0.80
Prolonged sedation requiring mechanical ventilation and continuous flumazenil infusion after routine doses of clorazepam for alcohol withdrawal syndrome. Intensive Care Med (1999) 0.80
Molecular and cellular biology of mammalian progesterone receptors. Recent Prog Horm Res (1989) 0.80
Protein S inherited qualitative deficiency: novel mutations and phenotypic influence. J Thromb Haemost (2010) 0.79
Protracted anuria due to active vasoconstriction in primary or secondary malignant hypertension. Nephrol Dial Transplant (1990) 0.79
The range of chronic demyelinating neuropathy of infancy: a clinico-pathological and genetic study of 15 unrelated cases. J Neurol (2001) 0.79
The effects of transdermal and oral estrogen/progesterone regimens on free and total protein S in postmenopausal women. Thromb Haemost (2001) 0.79
Hemolytic-uremic syndrome with anticardiolipin antibodies revealing paraneoplastic systemic scleroderma. Nephron (1991) 0.79
Immunolocalization of steroid hormone receptors in normal and tumour cells: mechanisms of their cellular traffic. Cancer Surv (1992) 0.78
Survival and differentiation of porcine hepatocytes encapsulated by semiautomatic device and allotransplanted in large number without immunosuppression. J Hepatol (2001) 0.78
Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5. J Pharm Pharmacol (1999) 0.78
Increased risk of atherosclerosis in women after the menopause. BMJ (1989) 0.77
Semiautomatic macroencapsulation of fresh or cryopreserved porcine hepatocytes maintain their ability for treatment of acute liver failure. Cell Transplant (2001) 0.77
Array comparative genomic hybridization analysis of small supernumerary marker chromosomes in human infertility. Reprod Biomed Online (2011) 0.77
Variability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteers. Br J Clin Pharmacol (2001) 0.77
VKORC1 genetic polymorphism and risk of venous thromboembolism in postmenopausal women: new findings and meta-analysis. J Thromb Haemost (2009) 0.77
[Management of high risk pregnancy in sickle cell disease by a strategy of prophylactic red cell transfusion or automated red cell exchange]. Transfus Clin Biol (2007) 0.77
Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction Study. Atherosclerosis (2001) 0.76
[Deep venous thrombosis: epidemiology, acquired risk factors]. Ann Cardiol Angeiol (Paris) (2002) 0.76
Therapeutic management in ambulatory elderly patients with atrial fibrillation: the S.AGES cohort. J Nutr Health Aging (2015) 0.76
Re: "Hormone replacement therapy and risk of hospitalization for venous thromboembolism: a population-based study in southern Europe". Am J Epidemiol (1999) 0.75
Safety of combined oral contraceptive pills. Lancet (1996) 0.75
Pharmacokinetic and pharmacodynamic variability of fluindione in octogenarians. Clin Pharmacol Ther (2012) 0.75
Seasonal variations of plasma fibrinogen in elderly people. Lancet (1994) 0.75
Risk of venous thrombosis with hormone replacement therapy. Lancet (1996) 0.75
Influence of natural SERPINC1 mutations on ex vivo thrombin generation. J Thromb Haemost (2010) 0.75
Plasma 17beta estradiol is inversely correlated with circulating vascular cell adhesion molecule. Thromb Haemost (2000) 0.75
The uteroglobin gene, structure and interaction with the progesterone-receptor. Oxf Surv Eukaryot Genes (1984) 0.75
["Pseudomonas aeruginosa" in the hospital of Avellino, and the presence of colonies in the obstetric, pediatric and neonatal wards. A microbiological study of the environment and of hygienic and prophylactic measures (author's transl)]. Quad Sclavo Diagn (1979) 0.75
[Molecular pharmacogenetics in hospital laboratories in France: current data and future prospects]. Ann Pharm Fr (2007) 0.75